Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,182 across all filing types
Latest filing 2021-12-31 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Intimation regarding issuance of duplicate share certificate.
Regulatory Filings
2021-12-31 English
Lupin Receives Approval from U.S. FDA for Sevelamer Carbonate for Oral Suspension.
Regulatory Filings Classification · 95% confidence The document is a press release announcing the receipt of U.S. FDA approval for a pharmaceutical product (Sevelamer Carbonate for Oral Suspension) by Lupin Limited. It is addressed to stock exchanges as a disclosure pursuant to SEBI regulations. The content is an announcement of a regulatory approval event and does not contain financial statements, detailed financial analysis, or management discussion. The document length is 4006 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication that this is a full annual or quarterly report, audit report, or earnings release. It is not a call transcript, board change, or legal proceeding. The document is best classified as a Regulatory Filing (RNS) because it is a regulatory disclosure announcement that does not fit into other specific categories.
2021-12-25 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the receipt of U.S. FDA approval for a pharmaceutical product (Sevelamer Carbonate for Oral Suspension) by Lupin Limited. It is addressed to stock exchanges as a disclosure pursuant to SEBI regulations. The content is a corporate announcement about regulatory approval and product launch, not a financial report, earnings release, or detailed investor presentation. The document length is 4016 characters, which is relatively short and consistent with a press release or regulatory announcement. There is no financial data, no management discussion, no voting results, no audit information, and no detailed report attached or referenced. Therefore, the document fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2021-12-25 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements), 2015, related to details of loss of share certificates and stop transfer requests. It is addressed to the National Stock Exchange of India and contains specific shareholder and share certificate details. The document is short (1936 characters) and serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or other report content. Therefore, it fits best under Regulatory Filings (RNS), which covers compliance documents and miscellaneous regulatory announcements that do not fit other categories.
2021-12-24 English
Intimation regarding loss of share certificate by the share holder.
Regulatory Filings
2021-12-24 English
Press Release
Regulatory Filings Classification · 95% confidence The document contains only placeholders for images and no textual content or substantive information. It is extremely short (206 characters) and does not contain any financial data, report titles, or regulatory references. Given the lack of content, it cannot be classified as a full report or detailed filing. It is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous or non-informative filings.
2021-12-24 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.